Hedged Liability (Statement of Financial Position)

Other

Eli Lilly Hedged Liability (Statement of Financial Position) decreased by 0.2% to $6.02B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $5.75B to $6.02B. Over 2 years (FY 2022 to FY 2024), Hedged Liability (Statement of Financial Position) shows relatively stable performance with a -1.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ3 2025
Metric ID: hedged_liability_statement_of_financial_position

Historical Data

12 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$5.45B$5.58B$5.57B$5.38B$5.67B$5.54B$5.50B$5.75B$5.34B$5.54B$6.03B$6.02B
QoQ Change—+2.4%-0.2%-3.4%+5.4%-2.3%-0.7%+4.5%-7.1%+3.7%+8.8%-0.2%
YoY Change————+4.0%-0.7%-1.3%+6.9%-5.8%+0.0%+9.6%+4.7%
Range$5.34B – $6.03B
CAGR+3.7%
Avg YoY Growth+2.2%
Median YoY Growth+2.0%

Frequently Asked Questions

What is Eli Lilly's hedged liability (statement of financial position)?
Eli Lilly (LLY) reported hedged liability (statement of financial position) of $6.02B in Q3 2025.
How has Eli Lilly's hedged liability (statement of financial position) changed year-over-year?
Eli Lilly's hedged liability (statement of financial position) increased by 4.7% year-over-year, from $5.75B to $6.02B.
What is the long-term trend for Eli Lilly's hedged liability (statement of financial position)?
Over 2 years (2022 to 2024), Eli Lilly's hedged liability (statement of financial position) has grown at a -1.0% compound annual growth rate (CAGR), from $5.45B to $5.34B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.